AI assistant
Vodafone Group PLC — Director's Dealing 2020
Aug 14, 2020
5275_dirs_2020-08-14_2db1c3e2-e3e4-4135-982d-3f6aa78d61b5.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 1966W
Vodafone Group Plc
14 August 2020
VODAFONE GROUP PLC
(the "Company")
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS
Purchase of shares through Dividend Reinvestment
Pursuant to a Dividend Reinvestment Plan offered to shareholders of the Company, the below individual acquired shares on 13 August 2020.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Serpil Timuray
2
Reason for the notification
a)
Position/status
Vodafone Chief Executive Officer - Europe Cluster
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Vodafone Group Plc
b)
LEI
549300MSQV80HSATBG53
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Ordinary shares of US$0.20 20/21 each in Vodafone Group Plc (ISIN: GB00BH4HKS39)
b)
Nature of the transaction
Purchase of shares through Dividend Reinvestment Plan
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| GBP 1.188412 | 40,984 |
d)
Aggregated information: volume, Price
Aggregated volume: 40,984 Ordinary shares
Aggregated price: GBP 48,705.88
e)
Date of the transaction
2020-08-13
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHFIFEATRISLII